Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III.

@article{Shalit2019EpidemiologyOH,
  title={Epidemiology of hallucinogen use in the U.S. results from the National epidemiologic survey on alcohol and related conditions III.},
  author={Nadav Shalit and J{\"u}rgen Rehm and Shaul Lev-Ran},
  journal={Addictive behaviors},
  year={2019},
  volume={89},
  pages={
          35-43
        }
}

Psychosocial Correlates and Early Substance Abuse Associated With Lifetime Hallucinogen Use Among Hispanic Young Adults

It is revealed that those most likely to report lifetime hallucinogen use were male, used alcohol, marijuana, cigars, cigarettes, inhalants, and cocaine before the age of 21, and binge drank in the past 30 days.

Adolescent and adult time trends in US hallucinogen use, 2002-19: any use, and use of ecstasy, LSD and PCP.

Since 2002, hallucinogen use in the United States has decreased among adolescents but increased in adults and is now estimated to affect more than 3 million adults aged 26+ years and more than 5.5million adults aged 18+ years.

Racial/ethnic differences in prevalence of hallucinogen use by age cohort: Findings from the 2018 National Survey on Drug Use and Health

Lifetime hallucinogen use was most prevalent among non-Hispanic White and multi-racial individuals, while Black/African Americans reported the lowest rates of use.

Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019

Findings should inform public health initiatives regarding potential benefits and risks of hallucinogen use among racial/ethnic groups and women.

Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users

Stakeholders should consider these results particularly when deciding on legal classifications for these substances, as the study findings suggest that NPDs should not be in the same class as NPSs.

Faces of HPPD: Hallucinogen Persisting Perception Disorder Patient Survey Results and a Descriptive Analysis of Patient Demographics, Medical Background, Drug Use History, Symptoms, and Treatments

HPPD is an understudied mental disorder that has a complex and unpredictable nature with overlapping psychiatric, psychological, and neurological symptoms and concern for patients’ well-being.

References

SHOWING 1-10 OF 81 REFERENCES

Psychedelics and Mental Health: A Population Study

It was found that in several cases psychedelic use was associated with lower rate of mental health problems, and use of psychedelics was not found to be an independent risk factor formental health problems.

Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Findings indicate an urgent need to destigmatize DUD and educate the public, clinicians, and policy makers about its treatment to encourage affected individuals to obtain help.

Patterns of current and lifetime substance use in schizophrenia.

The picture emerging from this study replicates the high rate of substance abuse in persons with schizophrenia reported in North American studies but differs from the latter in finding a slightly different pattern of substances abused (i.e., absence of cocaine), reflecting relative differences in the availability of certain drugs.

Psychedelics not linked to mental health problems or suicidal behavior: A population study

Overall, it is difficult to see how prohibition of psychedelics can be justified as a public health measure, after adjusting for sociodemographics, other drug use and childhood depression.

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III.

The NESARC-III data indicate an urgent need to educate the public and policy makers about AUD and its treatment alternatives, to destigmatize the disorder, and to encourage those who cannot reduce their alcohol consumption on their own, despite substantial harm to themselves and others, to seek treatment.

The link between use of psychedelic drugs and mental health problems

It is argued that the authors’ conclusions in their latest paper are not substantiated by their results and will propose supplemental analyses to validate or potentially revise their conclusions.

Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population

It is indicated thatclassic psychedelics may hold promise in the prevention of suicide, supporting the view that classic psychedelics’ most highly restricted legal status should be reconsidered to facilitate scientific study, and suggesting that more extensive clinical research with classic psychedelic is warranted.

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

The findings show that environmental factors may be important determinants of substance abuse among schizophrenic-spectrum patients and that clinical differences related to abuse vary with different types of drugs.

Substance abuse in women.

...